Reengineering the pharmaceutical industry by crash-testing molecules

  • Peter W. Swaan, Sean Ekins
  • Drug Discovery Today, September 2005, Elsevier
  • DOI: 10.1016/s1359-6446(05)03557-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Sean Ekins